246 related articles for article (PubMed ID: 19208562)
21. Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease.
Omori S; Hida M; Fujita H; Takahashi H; Tanimura S; Kohno M; Awazu M
J Am Soc Nephrol; 2006 Jun; 17(6):1604-14. PubMed ID: 16641154
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of p38 mitogen-activated protein kinase pathway as prophylaxis of postoperative ileus in mice.
Wehner S; Straesser S; Vilz TO; Pantelis D; Sielecki T; de la Cruz VF; Hirner A; Kalff JC
Gastroenterology; 2009 Feb; 136(2):619-29. PubMed ID: 19014943
[TBL] [Abstract][Full Text] [Related]
23. Activation of p38 mitogen-activated protein kinase in spinal microglia contributes to incision-induced mechanical allodynia.
Wen YR; Suter MR; Ji RR; Yeh GC; Wu YS; Wang KC; Kohno T; Sun WZ; Wang CC
Anesthesiology; 2009 Jan; 110(1):155-65. PubMed ID: 19104183
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis induction by p38 MAPK inhibitor in human colon cancer cells.
Tsuchiya T; Tsuno NH; Asakage M; Yamada J; Yoneyama S; Okaji Y; Sasaki S; Kitayama J; Osada T; Takahashi K; Nagawa H
Hepatogastroenterology; 2008; 55(84):930-5. PubMed ID: 18705300
[TBL] [Abstract][Full Text] [Related]
25. Role of p38 mitogen-activated protein kinase on cardiac dysfunction after hemorrhagic shock in rats.
Sato H; Tanaka T; Kasai K; Kita T; Tanaka N
Shock; 2007 Sep; 28(3):291-9. PubMed ID: 17545949
[TBL] [Abstract][Full Text] [Related]
26. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
[TBL] [Abstract][Full Text] [Related]
27. Infiltrating dendritic cells contribute to local synthesis of C1q in murine and human lupus nephritis.
Castellano G; Trouw LA; Fiore N; Daha MR; Schena FP; van Kooten C
Mol Immunol; 2010 Jul; 47(11-12):2129-37. PubMed ID: 20417969
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of autoimmune disease in Fas-deficient mice by treatment with a cytotoxic benzodiazepine.
Bednarski JJ; Warner RE; Rao T; Leonetti F; Yung R; Richardson BC; Johnson KJ; Ellman JA; Opipari AW; Glick GD
Arthritis Rheum; 2003 Mar; 48(3):757-66. PubMed ID: 12632430
[TBL] [Abstract][Full Text] [Related]
29. Abrogation of skin disease in LUPUS-prone MRL/FASlpr mice by means of a novel tylophorine analog.
Choi JY; Gao W; Odegard J; Shiah HS; Kashgarian M; McNiff JM; Baker DC; Cheng YC; Craft J
Arthritis Rheum; 2006 Oct; 54(10):3277-83. PubMed ID: 17009262
[TBL] [Abstract][Full Text] [Related]
30. Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via beta-adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia.
Morioka N; Tanabe H; Inoue A; Dohi T; Nakata Y
Neurochem Int; 2009 Sep; 55(4):226-34. PubMed ID: 19524113
[TBL] [Abstract][Full Text] [Related]
31. Lack of FGF-1 overexpression during autoimmune nephritis in the kidneys of MRL lpr/lpr mice.
Madiai F; Hackshaw KV
Res Commun Mol Pathol Pharmacol; 1999 Jan; 103(1):37-44. PubMed ID: 10440569
[TBL] [Abstract][Full Text] [Related]
32. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
[TBL] [Abstract][Full Text] [Related]
33. Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus.
Zeller GC; Hirahashi J; Schwarting A; Sharpe AH; Kelley VR
J Am Soc Nephrol; 2006 Jan; 17(1):122-30. PubMed ID: 16291836
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of FR167653 on chronic allograft nephropathy by inhibiting p38 MAPK in rats.
Tan HB; Feng Y; Liu M; Wu YC
Transplant Proc; 2008 Jun; 40(5):1685-9. PubMed ID: 18589173
[TBL] [Abstract][Full Text] [Related]
35. JNK1/c-Jun and p38 alpha MAPK/ATF-2 pathways are responsible for upregulation of Fas/FasL in human chronic myeloid leukemia K562 cells upon exposure to Taiwan cobra phospholipase A2.
Chen KC; Chiou YL; Chang LS
J Cell Biochem; 2009 Oct; 108(3):612-20. PubMed ID: 19670268
[TBL] [Abstract][Full Text] [Related]
36. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
37. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S
Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
[TBL] [Abstract][Full Text] [Related]
38. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
Lu LD; Stump KL; Wallace NH; Dobrzanski P; Serdikoff C; Gingrich DE; Dugan BJ; Angeles TS; Albom MS; Mason JL; Ator MA; Dorsey BD; Ruggeri BA; Seavey MM
J Immunol; 2011 Oct; 187(7):3840-53. PubMed ID: 21880982
[TBL] [Abstract][Full Text] [Related]
39. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.
Conrad DM; Furlong SJ; Doucette CD; Boudreau RT; Hoskin DW
Cell Signal; 2009 Aug; 21(8):1298-307. PubMed ID: 19324083
[TBL] [Abstract][Full Text] [Related]
40. High mobility group box protein-1 in experimental autoimmune uveoretinitis.
Watanabe T; Keino H; Sato Y; Kudo A; Kawakami H; Okada AA
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2283-90. PubMed ID: 19151394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
